Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC) Eric Van Cutsem, MD, PhD University Hospitals Gasthuisberg/Leuven, Leuven,
Phase III CORRECT trial of regorafenib in metastatic colorectal cancer ( mCRC )
